Q.G.C.M. van Hoesel - Concepedia

Author

Q.G.C.M. van Hoesel

Also Known As

Q G C M van Hoesel, Q G van Hoesel, Q. G. C. M. van Hoesel, Q.G.C.M van Hoesel, Q.G.C.M. Van Hoesel, Q.G.C.M. van Hoesel, Quirinus G.C.M. van Hoesel

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Utrecht University Leiden University Medical Center Radboud University Medical Center National Institute for Public Health and the Environment

About

Q.G.C.M. van Hoesel is an author at Radboud University Nijmegen specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	472
2	Pathology	5	5	226
3	Pharmacology	5	5	282
4	Immunology	3	3	175
5	Biochemistry	1	1	39

Q.G.C.M. van Hoesel

Publications

636

Citations

H-Index

Page 1

	Year	Citations
Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat. Q.G.C.M. van Hoesel, Peter A. Steerenberg, Daan J.A. Crommelin, PubMed Antitumor ActivityImmunologyPathologyLou/m Wsl RatMetronomic Chemotherapy	1984	120
Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group L Švancárová, Jean‐Yves Blay, Ian Judson, European Journal of Cancer Bone Sarcoma GroupMalignant DiseaseMedicineSurgical PathologyPhase Ii Study	2002	119
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer Sjoerd Rodenhuis, M. Bontenbal, Q.G.C.M. van Hoesel, Annals of Oncology Breast OncologyOncologyHer2/neu-negative Breast CancerMedicineBreast Cancer	2006	72
Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy Juliane Hannemann, Petra Kristel, Harm van Tinteren, British Journal of Cancer	2006	62
Prospective Study of Long-Term Impact of Adjuvant High-Dose and Conventional-Dose Chemotherapy on Health-Related Quality of Life Ciska Buijs, Sjoerd Rodenhuis, Caroline Seynaeve, Journal of Clinical Oncology	2007	39
Liposomes as drug carrier system for cis-diamminedichloroplatinum (II) Peter A. Steerenberg, G. Storm, Gerard de Groot, Cancer Chemotherapy and Pharmacology Drug Carrier SystemLipid MovementBiochemistryDrug Delivery Systems	1988	39
A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat G. Storm, Q.G.C.M. van Hoesel, Gerard de Groot, Cancer Chemotherapy and Pharmacology MedicineImmunologyPharmacotherapyLou/m Wsl RatPharmacology	1989	38
Randomized Phase II Study of Docetaxel versus Doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Jaap Verweij, S.M. Lee, W. Ruka, UCL Discovery (University College London) Docetaxel Versus DoxorubicinBone Sarcoma GroupMalignant DiseaseMedicineCancer Management	2000	36
Analysis of adriamycin and adriamycinol in micro volumes of rat plasma A.M.B. Bots, W. J. van Oort, J. Noordhoek, Journal of Chromatography B Biomedical Sciences and Applications MedicinePathologyPharmacologyRat PlasmaPharmacokinetics	1983	35
Osteosarcoma: Oncologic and functional results. A single institutional report covering 22 years A Renard, R.P.H. Veth, H.W.B. Schreuder, Journal of Surgical Oncology	1999	24

Page 1